SIAM NATURAL™
brand
Cocos nucifera L.
Palm Oil for Heart Health, Immune
Support, and Weight Loss
Coconuts and coconut oil have been traditional,
staple foods of Asia, Africa, Central America and the Pacific Islands for
thousands of years.
Pacific Islanders who eat traditional diets have a reputation for good health
and strong beautiful bodies. Many of these traditional diets obtain 30% to
60% of their calories from coconuts and palm oil. They tend to have normal
cholesterol levels and little to no cardiovascular disease.(39)
Prior to the early 1900's, coconut oil was an important
dietary fat in the United States. At that time cardiovascular disease was relatively
uncommon. Subsequently, palm oil has virtually disappeared, replaced by soybean
oil, corn oil, canola oil and the hydrogenated
versions of these oils. While these domestic oils and their synthetic derivatives
are under suspicion of causing a host of health problems,
palm oil research is rediscovering it's multiple health benefitsl.
Today, in countries where coconut oil is still widely used,
heart and vascular disease remains uncommon. Palm oil is converted by the
body into the hormone pregnenolone. It also has immune-stimulating and anti-oxidant
action. Coconut oil also promotes thermogenesis
and increased metabolism (supporting thyroid and mitochondrial function).
Coconut Oil and Cholesterol
Although coconut oil is a saturated fat, research has shown
that it has a neutral effect on cholesterol and triglyceride levels. Being a
saturated fat, it is stable and not oxidized easily, probably explaining why
it does not contribute to coronary heart disease.
(3)(5)(12)(15)(31)(32)(34)(35)(36)(37)(38)(44)(48)(49)
Coconut Oil - Immune Support and Antibiotic
Properties
Two thirds of coconut oil consists of Medium Chain Triglycerides.
These MCTs consist of lauric acid (48 percent), capric acid (7 percent)
and caprylic acid (8 percent). These fatty acids and their monoglycerides are
extremely powerful antimicrobial agents, effective against a
broad range of pathologic bacteria, viruses, fungi, yeasts, and protozoa.
The antivital properties of lauric acid was first discovered
when researchers were investigating the anti-infective properties of human breast
milk. Human and mammalian breast milk are rich in lauric acid. These fatty acids
and monoglycerides provide protection against infections
to babies, whose immune systems are still developing. When nursing mothers include
coconut oil in their diet, the level of these fatty acids
in their breast milk can triple. (6)(18)(20)(21)(22)(28)(45)(52).
Anti-Viral Mechanism of Coconut Oil and Monolaurin
The monoglycerides have antiviral properties, diglycerides
and triglycerides do not. Of the saturated fatty acids, lauric acid has greater
antiviral activity than either caprylic acid or myristic acid. It has been reported
that monolaurin is more effective in inactivating viruses and
other infective agents than lauric acid. The exact difference between coconut
oil and monolaurin as an anti-infective agent is unclear
because they have not been adequately tested and studied. Most of the clinical
studies have been done on Monolaurin. Monolaurin is a
glyceride ester derivative of lauric acid; an activated form of lauric acid.
Monolaurin dissolves the lipids and phospholipids in the
envelope of the virus causing the disintegration of the virus envelope effectively
lysing the plasma membrane. There is also evidence that signal transduction
is also interfered with inhibiting the multiplication of the virus.
(9)(16)(18)(21)(22)(51)
Viruses Inactivated by Coconut Oil
Some of the viruses inactivated by these lipids are HIV,
measles virus, herpes simplex virus-1 (HSV-1), herpes simplex virus-2 (HSV-2),
vesicular stomatitis virus (VSV), visna virus, and cytomegalovirus (CMV). Many
of the pathogenic organisms reported to be inactivated by
these antimicrobial lipids are those known to be responsible for opportunistic
infections in HIV-positive individuals. In addition to viruses,
several bacteria and fungi have also been reported to be suppressed by monolaurin
and coconut oil.
(1)(11)(14)(22)(24)(26)(27)(33)(40)(43)(45)(46)(50)(51)
Coconut Oil - Thermogenesis and Weight Loss
Research has shown that coconut oil increases thermogenesis,
the rate of burning calories to produce heat and energy from food.
Research has also shown that animals fed MCT oils had smaller fat pads and a
number of key adipogenic genes were down-regulated.
MCT fed animals also had improved insulin sensitivity, glucose tolerance and
reduced adipose tissue lipoprotein lipase.
It has become clear that individuals consuming coconut
oil rather than soybean, olive or other LCT (long chain triglyceride) oils have
an
edge in losing weight and keeping it off. (2)(10)(15)(30)(44)(48)(49)
Organic Virgin Coconut Oil VCO
There are basically two grades of coconut oil available:
RBD (refined, bleached, deodorized) and virgin coconut oil. RBD oil is subjected
to
high heat, filtration, and processed with sodium hydroxide. A properly produced
RBD oil is an acceptable food product.
The ultimate coconut oil is organic virgin coconut oil. The lauric acid content
typically runs 50-55 percent making it a particularly potent
antimicrobial. This oil has a distinct coconut smell and taste where RBD oil
is usually bland, with no coconut taste or odor.
How to Use Coconut Oil
You can use coconut oil for all frying and stir frying.
It is heat stable and has a shelf life of over one year. You can also use it
as a direct substitute
for butter, ghee, margarine and other culinary oils. When warmed (it needs to
be liquefied, it solidifies at 70 degrees F) and combined with
a culinary vinegar and herbs, it makes an excellent salad dressing.
Dosage: How much Coconut Oil
Cocos nucifera L lauric acid or monolaurin is needed?
Infants probably consume between 0.3 and 1 gram per kilogram
of body weight if they are fed human milk or an enriched infant formula
that contains coconut oil. This amount appears to have always been protective
to some degree. Extrapolating breastmilk content of lauric
acid and scaling the quantity to the body weight of an adult, an estimated intake
of approximately 24 grams of coconut oil per day may
provide protective levels for an adult. This is the equivalent of 3.5 tablespoons
of coconut oil, 10 ounces of coconut milk or 7 ounces of
raw coconut (approximately one half of a raw coconut per day). The Dayrit (8)
study of Monolaurin and coconut oil as a therapy for HIV
used dosages of 7.5 to 22 grams of monolaurin per day in three divided doses
or 45 ml. (approximately 3 tablespoons) of coconut oil
per day. The coconut oil and monolaurin both demonstrated a beneficial result
in reducing viral loads and improving white cell counts.
Growing children probably need about the same amount as adults.
Safety Precautions and Side Effects
Coconut oil is food and can be consumed freely without
any adverse effects. The only precaution is to keep your total calories within
the
range that is appropriate for your body type and activity level. Lauric acid
from coconut oil is converted into monolaurin in the human
body. Monolaurin is also considered to be a food.
Where to Get Virgin Organic Coconut Oil
Organic Virgin Coconut oil from south Thailand is considered
some of the best in the world. Siam Natural 100% organic virgin coconut oil
can be obtained on-line from Paradisemoon.com Kealakekua, Hawaii USA
References;
(1) Ascherio A., Munger K.L., Lenette E.T., Spiegelman D., Hernan M.A., Olek M.J.,
Hankinson S.E., and Hunter, D.J. Epstein-Barr virus antibodies and risk of multiple
sclerosis: a prospective study. JAMA 286(24:3127-9, Dec. 26th, 2001.
(2) Awad AB. Effect of dietary lipids on composition and glucose utilization by
rat adipose tissue. Journal of Nutrition 111:34-39, 1981.
(3) Bierenbaum JL, Green DP, Florin A, Fleishman AI, Caldwell AB. Modified-fat
dietary management of the young male with coronary disease: a five-year report.
Journal of the American Medical Association 202:1119-1123;1967.
(4) Beuchat LA. Comparison of antiviral activities of potassium sorbate, sodium
benzoate and glycerol and sucrose esters of fatty acids. Appi. Environ. Microbiol.
39:1178, 1980.
(5) Blackburn GL, Kater G, Mascioli EA, Kowalchuk M, Babayan VK, kBistrian BR.
A reevaluation of coconut oil's effect on serum cholesterol and atherogenesis.
The Journal of the Philippine Medical Association 65:144-152;1989.
(6) Boddie RL and Nickerson SE. Evaluation of postmilking teat germicides containing
Lauricidin, saturated fatty acids, and lactic acid. J. Dairy Sci. 75(6):1725-30,
1992.
(7) Cohen SS. Strategy for the chemotherapy of infectious diseases. Science 197:431,
1977
(8) Dayrit, Conrado S. MD. Coconut Oil in Health and Disease: Its and Monolaurin's
Potential as Cure for HIV / AIDS, XXXVII Cocotech Meeting, Chennai, India, July
25, 2000
(9) Dulbecco A. Interference with viral multi- plication. In: Virology, Dulbecco,
A. and Ginsberg, H. edit, Harper & Row, Philadelphia, 1980.
(10) Enig, M. Coconut: In support of good health in the 21st century. 1999. www.mercola.com/2001/jul/28/
coconut_health.htm.
(11) Enig, MG: Coconut Oil: An Anti-bacterial, Anti-viral Ingredient for Food,
Nutrition and Health., AVOC Lauric Symposium, Manila, Philippines, Oct. 17, 1997.
(12) Eraly MG. IV. Coconut oil and heart attack. Coconut and Coconut Oil in Human
Nutrition, Proceedings. Symposium on Coconut and Coconut Oil in Human Nutrition.
27 March 1994. Coconut Development Board, Kochi, India, 1995, pp 63-64.
(13) Fife, B. The Healing Miracles of Coconut Oil. Colorado Springs: Health Wise
Pub; 2003:15.
(14) Fletcher RD, Albers AC, Albertson JN, Kabara JJ. Effects of monoglycerides
on mycoplasma pneumoniae growth, in The Pharmacological Effect of Lipids II (JJ
Kabara, ed) American Oil Chemists' Society, Champaign IL, 1985, pp.59-63.
(15) Han, J. et al. Medium-chain oil reduces fat mass & down-regulates expression
of adipogenic genes in rats. Obes Res 2003, 11:734-44.
(16) Hierholzer, J.C. and Kabara, J.J. In vitro effects of monolaurin compounds
on enveloped RNA and DNA viruses. Journal of Food Safety 4:1-12;1982.
(17) Hierholzer, JC and Kabara, JJ. In vitro effects of monolaurin compounds on
enveloped RNA and DNA viruses., J. Food Safety 4:1-12, 1982
(18) Isaacs CE, Thormar H. Membrane-disruptive effect of human milk: inactivation
of enveloped viruses. Journal of Infectious Diseases 154:966-971;1986.
(19) Isaacs CE, Thormar H. The role of milk-derived antimicrobial lipids as antiviral
and antibacterial agents in Immunology of Milk and the Neonate (Mestecky J, et
al, eds) Plenum Press, New York, 1991.
(20) Isaacs CE. The antimicrobial function of milk lipids. Adv. Nutr. Res. 10:271-85,
2001.
(21) Isaacs CE, Schneidman K. Enveloped Viruses in Human and Bovine Milk are Inactivated
by Added Fatty Acids(FAs) and Monoglycerides(MGs). FASEB Journal. Abstract 5325,
p.A1288, 1991.
(22) Isaacs CE, Kashyap S, Heird WC, Thormar H. Antiviral and antibacterial lipids
in human milk and infant formula feeds. Archives of Disease in Childhood 65:861-864;1990.
(23) Isaacs CE, Litov RE, Marie P, Thormar H. Addition of lipases to infant formulas
produces antiviral and antibacterial activity. Journal of Nutritional Biochemistry
3:304-308;1992.
(24) Ismail-Cassim, N et al. Inhibition of the uncoating of bovine enterovirus
by short chain fatty acids. J. Gen. Virol. 71(10):2283-9, 1990.
(25) Kabara JJ. Fatty acids and derivatives as antimicrobial agents -- A review,
in The Pharmacological Effect of Lipids (JJ Kabara, ed) American Oil Chemists'
Society, Champaign IL, 1978, .
(26) Kabara JJ et al. Fatty acids and derivatives as antimicrobial agents. Antimicrob.
Agents Chemother. 2:23, 1972
(27) Kabara JJ. Inhibition of staphylococcus aureaus in The Pharmacological Effect
of Lipids II (JJ Kabara, ed) American Oil Chemists' Society, Champaign IL, 1985,
pp.71-75.
(28) Kabara JJ. Lipids as host-resistance factors of human milk. Nutr. Rev. 38:65,
1980.
(29) Kabara, J. Health oils from the tree of life (Nutritional and health aspects
of coconut oil). www.coconutoil.com/research.htm.
(30) Kasai, M. Comparison of diet-induced thermogenesis of foods containing medium-
versus long-chain triacylglycerols. J Nutr Sci Vitaminol (Tokyo) 2002, 48:536-40.
(31) Kaunitz H, Dayrit CS. Coconut oil consumption and coronary heart disease.
Philippine Journal of Internal Medicine 30:165-171;1992.
(32) Keys A, Anderson JT, Grande F. Prediction of serum-cholesterol responses
of man to changes in the diet. Lancet, 959;1957. </p>
(33) Kohn A. et al. Unsaturated free fatty acids inactivated animal envelope viruses.
Arch. Virol. 66:301-306, 1980
(34) Kurup PA, Rajmohan T. II. Consumption of coconut oil and coconut kernel and
the incidence of atherosclerosis. Coconut and Coconut Oil in Human Nutrition,
Proceedings. Symposium on Coconut and Coconut Oil in Human Nutrition. 27 March
1994. Coconut Development Board, Kochi, India, 1995, pp 35-59.
(35) Kumar, P. The role of coconut and coconut oil in coronary heart disease in
Kerala, South India. Trop Doct 1997, 27:215-17. 7. 2 op. cit., 58.
(36) Lim-Sylianco CY. Anticarcinogenic effect of coconut oil. The Philippine Journal
of Coconut Studies 12:89-102;1987.
(37) Mendis S, Wissler RW, Bridenstine RT, Podbielski FJ. The effects of replacing
coconut oil with corn oil on human serum lipid profiles and platelet derived factors
active in atherogenesis. Nutrition Reports International 40:No.4;Oct.1989.
(38) Mendis, S. and Kumarasunderam, R. The effect of daily consumption of coconut
fat and soya-bean fat on plasma lipids and lipoproteins of young normolipidaemic
men. Br J Nutr 1990, 63:547-52.
(39) Prior IA, Davidson F, Salmond CE, Czochanska Z. Cholesterol, coconuts, and
diet on Polynesian atolls: a natural experiment: the Pukapuka and Tokelau Island
studies. American Journal of Clinical Nutrition 34:1552-1561;1981.
(40) Projan SJ, Brown-Skrobot S, Schlievert PM, Vandenesch F, Novick RP. Glycerol
monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and
other staphylococcal exoproteins by interefering with signal transduction. Journal
of Bacteriology. 176:4204-4209;1994.
(41) Rabia S. et al. Inactivation of vesicular stomatitis virus by photosensitization
following incubation with a pyrene-fatty acid. Febs. Let. 270(12):9-10, 1990.
(42) Sands JA et al. Antiviral effects of fatty acids and derivatives. In: Pharmacological
Effects of Lipids. Am. Oil Chem. Soc: Champaign, 1979;75.
(43) Sands J et al. Extreme sensitivity of enveloped viruses, including herpes
simplex, to long chain unsaturated monoglycerides and alcohols. Antimicrobial
Agents and Chemotherapy 15(1):67-73, 1979.
(44) Sircar, S. and Kansra, U. Choice of cooking oils-myths and realities. J Indian
Med Assoc 1998, 96:304-07.
(45) Silver RK et al. Factors in human milk interfering with influenza-virus activities.
Science 123:932-933, 1956
(46) Simmons A. Herpes virus and multiple sclerosis. Herpes 8(3):60-3, Nov. 2001
(47) Smith RL. The Cholesterol Conspiracy. Warren H Green Inc. St. Louis, Missouri,
1991.
(48) St-Onge, M. et al. Medium-chain triglycerides increase energy expenditure
and decrease adiposity in overweight men. Obes Res 2003, 11:395-402.
(49) St-Onge, M. and Jones, P. Physiological effects of medium-chain triglycerides:
potential agents in the prevention of obesity. J Nutr 2002, 132:329-32.
(50) Tayag E, Dayrit CS, Santiago EG, Manalo MA, Alban PN, Agdamag DM, Adel AS,
Lazo S and Espallardo N. Monolaurin and Coconut Oil as Monotherapy for HIV-AIDS,
Pilot Trial. For Publication.
(51) Thormar H, Isaacs EC, Brown HR, Barshatzky MR, Pessolano T. Inactivation
of enveloped viruses and killing of cells by fatty acids and monoglycerides.
Antimicrobial agents and chemotherapy 1987;31:27-31.
(52) Welsh JK, May JT. Anti-infective properties of breast milk. J. Pediatrics
94, 1-9, 1979.
Siam
Natural™ Herbal Products
Siam
Natural Main Products page
|
These statements have not been evaluated by the FDA. These
products are not intended to diagnose, treat, cure, or prevent any disease.
|
|
Intellectual
properties contained herein (c)
(p) copyright
2001-2008 worldwide rights reserved
Paradisemoon.com
a
Bali
Lau Entertainment
Group, Company Hawaii, USA
|
